The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.
The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.
The bill to raise the debt ceiling and reduce the deficit would slash billions of dollars for basic scientific and medical research.
A new report says the FDA’s current oversight of medical devices is inadequate and should be revamped.
Gut bacteria that feed on healthy food appear to amplify the nutritional benefits of those foods. However, they also appear to amplify the undesirable effects of unhealthy food. Here are a few examples. Read the full story.
With mounting interest from biotechs, Big Pharma, and the federal government, research on rare diseases is burgeoning.
August 1, 2011
Meet some of the people featured in the August 2011 issue of The Scientist.
Gut bacteria may be the missing piece that explains the connection between diet and cancer risk.
A snapshot of the most highly ranked articles in microbiology and related areas, from Faculty of 1000
Fenugreek seeds are banned in Europe after authorities point the finger at them as a potential source of the deadly E. coli outbreak.